Bone marrow lesions predict progression of cartilage defects and loss of cartilage volume in healthy middle-aged adults without knee pain over 2 yrs

被引:64
作者
Wluka, Anita [1 ,2 ]
Wang, Y. [1 ]
Davies-Tuck, M. [1 ]
English, D. R. [3 ,4 ]
Giles, G. G. [4 ]
Cicuttini, Flavia M. [1 ]
机构
[1] Monash Univ, Sch Med, Alfred Hosp, Dept Epidemiol & Prevent Med, Prahran, Vic 3004, Australia
[2] Baker Heart Res Inst, Melbourne, Vic, Australia
[3] Univ Melbourne, Sch Populat Hlth, Parkville, Vic 3052, Australia
[4] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
osteoarthritis; cartilage; bone marrow lesions; cartilage defects; cartilage volume;
D O I
10.1093/rheumatology/ken237
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. In knee OA, the presence of bone marrow lesions (BMLs) predicts pain and progression of disease. Their occurrence has been described in healthy, pain-free subjects, but whether their presence affects change in cartilage is unknown. Methods. Two hundred and seventy-one healthy community-dwelling adults with no history of knee injury, knee pain or clinical knee OA had an MRI performed on their dominant knee at baseline and 2 yrs later to assess the relationship between the presence of BMLs at baseline and change in tibiofemoral cartilage defects and tibial cartilage volume over 2 yrs. Results. BMLs were present in 37 (14%) subjects. Cartilage defects were more likely to progress rather than remain stable or regress in subjects with BMLs compared with those without BMLs (P=0.04). The odds of cartilage defects progressing in the tibiofemoral compartment of the knee where BMLs were present compared with where BMLs were absent was 2.6 (95% CI 1.2, 5.3; P=0.01). Where 'very large' BMLs were present, there was a trend for increased annual tibial cartilage volume loss (46.4 mm(3)/yr; P=0.07). Conclusions. These data suggest that BMLs are associated with change in knee cartilage over 2 yrs in asymptomatic subjects. Increased progression of cartilage defects is seen with increasing size of BMLs. It will be important to determine in future studies whether BMLs directly cause change in cartilage over 2 yrs, or act as a marker of another factor that facilitates these changes.
引用
收藏
页码:1392 / 1396
页数:5
相关论文
共 29 条
[1]   DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE [J].
ALTMAN, R ;
ASCH, E ;
BLOCH, D ;
BOLE, G ;
BORENSTEIN, D ;
BRANDT, K ;
CHRISTY, W ;
COOKE, TD ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MANKIN, H ;
MCSHANE, DJ ;
MEDSGER, T ;
MEENAN, R ;
MIKKELSEN, W ;
MOSKOWITZ, R ;
MURPHY, W ;
ROTHSCHILD, B ;
SEGAL, M ;
SOKOLOFF, L ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :1039-1049
[2]   Association of bone marrow lesions with knee structures and risk factors for bone marrow lesions in the knees of clinically healthy, community-based adults [J].
Baranyay, Ferencz J. ;
Wang, Yuanyuan ;
Wluka, Anita ;
Dallas, R. ;
Giles, Graham G. ;
Sullivan, Richard O. ;
Cicuttini, Flavia M. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2007, 37 (02) :112-118
[3]   Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee - Results of the two-year multinational knee osteoarthritis structural arthritis study [J].
Bingham, Clifton O., III ;
Buckland-Wright, J. Chris ;
Garnero, Patrick ;
Cohen, Stanley B. ;
DougadoS, Maxime ;
Adarni, Silvano ;
Clauw, Daniel J. ;
Spector, Timothy D. ;
Pelletier, Jean-Pierre ;
Raynauld, Jean-Pierre ;
Strand, Vibeke ;
Simon, Lee S. ;
Meyer, Joan M. ;
Cline, Gary A. ;
Beary, John F. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (11) :3494-3507
[4]   A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients [J].
Buckland-Wright, J. C. ;
Messent, E. A. ;
Bingham, C. O., III ;
Ward, R. J. ;
Tonkin, C. .
RHEUMATOLOGY, 2007, 46 (02) :257-264
[5]   The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis [J].
Carbone, LD ;
Nevitt, MC ;
Wildy, K ;
Barrow, KD ;
Harris, F ;
Felson, D ;
Peterfy, C ;
Visser, M ;
Harris, TB ;
Wang, BWE ;
Kritchevsky, SB .
ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3516-3525
[6]   Comparison of tibial cartilage volume and radiologic grade of the tibiofemoral joint [J].
Cicuttini, FM ;
Wluka, A ;
Forbes, A ;
Wolfe, R .
ARTHRITIS AND RHEUMATISM, 2003, 48 (03) :682-688
[7]   Association of cartilage defects with loss of knee cartilage in healthy, middle-age adults - A prospective study [J].
Cicuttini, FM ;
Ding, CH ;
Wluka, A ;
Davis, S ;
Ebeling, PR ;
Jones, G .
ARTHRITIS AND RHEUMATISM, 2005, 52 (07) :2033-2039
[8]   Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study [J].
Cicuttini, FM ;
Jones, G ;
Forbes, A ;
Wluka, A .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) :1124-1127
[9]   Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis [J].
Clegg, DO ;
Reda, DJ ;
Harris, CL ;
Klein, MA ;
O'Dell, JR ;
Hooper, MM ;
Bradley, JD ;
Bingham, CO ;
Weisman, MH ;
Jackson, CG ;
Lane, NE ;
Cush, JJ ;
Moreland, LW ;
Schumacher, HR ;
Oddis, CV ;
Wolfe, F ;
Molitor, JA ;
Yocum, DE ;
Schnitzer, TJ ;
Furst, DE ;
Sawitzke, AD ;
Shi, H ;
Brandt, KD ;
Moskowitz, RW ;
Williams, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08) :795-808
[10]   Association of prevalent and incident knee cartilage defects with loss of tibial and patellar cartilage - A longitudinal study [J].
Ding, CH ;
Cicuttini, FM ;
Scott, F ;
Boon, C ;
Jones, G .
ARTHRITIS AND RHEUMATISM, 2005, 52 (12) :3918-3927